14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 30th Aug 2023 TCRR stock ended at $1.48. During the day the stock fluctuated 0% from a day low at $1.48 to a day high of $1.48.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical TCR2 Therapeutics Inc. prices

Date Open High Low Close Volume
Oct 06, 2022 $1.80 $1.88 $1.77 $1.77 104 908
Oct 05, 2022 $1.82 $1.87 $1.77 $1.81 140 802
Oct 04, 2022 $1.79 $1.88 $1.76 $1.81 323 808
Oct 03, 2022 $1.80 $1.83 $1.69 $1.76 440 918
Sep 30, 2022 $1.65 $1.82 $1.60 $1.80 239 308
Sep 29, 2022 $1.78 $1.86 $1.72 $1.72 316 491
Sep 28, 2022 $1.77 $1.92 $1.72 $1.79 850 005
Sep 27, 2022 $1.77 $1.82 $1.69 $1.69 170 472
Sep 26, 2022 $1.86 $1.91 $1.72 $1.74 330 519
Sep 23, 2022 $1.96 $1.96 $1.84 $1.86 277 418
Sep 22, 2022 $2.12 $2.12 $1.94 $1.96 250 368
Sep 21, 2022 $2.11 $2.15 $2.07 $2.09 143 703
Sep 20, 2022 $2.16 $2.17 $2.11 $2.12 122 678
Sep 19, 2022 $2.22 $2.24 $2.12 $2.15 260 084
Sep 16, 2022 $2.43 $2.43 $2.20 $2.26 648 253
Sep 15, 2022 $2.40 $2.51 $2.38 $2.43 132 030
Sep 14, 2022 $2.55 $2.55 $2.33 $2.42 338 613
Sep 13, 2022 $2.52 $2.56 $2.45 $2.55 196 952
Sep 12, 2022 $2.40 $2.56 $2.40 $2.55 103 088
Sep 09, 2022 $2.42 $2.48 $2.38 $2.40 190 356
Sep 08, 2022 $2.41 $2.54 $2.37 $2.37 240 514
Sep 07, 2022 $2.45 $2.48 $2.37 $2.42 147 082
Sep 06, 2022 $2.49 $2.69 $2.45 $2.46 398 610
Sep 02, 2022 $2.63 $2.68 $2.50 $2.50 315 590
Sep 01, 2022 $2.71 $2.72 $2.45 $2.56 336 949
Click to get the best stock tips daily for free!

About TCR2 Therapeutics Inc.

TCR2 Therapeutics. TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal... TCRR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT